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Objectives: To assess prevalence and importance of urinary incontinence in females
(12 years). Based on the result we will adjust and individualize our preventative
treatment plan, in order to offer best possible treatment and support to prevent
urinary incontinence.
Methods: A questionnaire designed to answer questions on prevalence of urinary
incontinence and subjective experiences of urinary leakage was distributed to all
females >12 years of age attending Gothenburg CF centre.
Results: Response rate until today is 48% (30/63), 25 of them >18 years, with a
mean FEV1 of 73% predicted. There were 20 (67%) responders (mean FEV1 66%
pred) who experienced urinary incontinence, two of which admitted limitations
in participating in certain physical activities due to their urinary leakage. Five of
them admitted frustration due to their urinary incontinence, and 2 out of these
admitted social limitations and negative effects on mental health respectively. Ten
(33%) responders (mean FEV1 72% pred) denied urinary incontinence. Four out
of 5 females <18 years admitted urinary incontinence, though not to an extent
preventing them from participating in physical exercise.
Conclusion: Urinary incontinence is common already from childhood and may
have negative impact on social, physical and psychological aspects of life.
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Background: There is large variation in airway clearance techniques (ACT’s) used by people with
CF (PWCF). However, the types of ACT’s used in the UK have not been systematically explored.
Objectives:
1. Describe the ACT’s used by adolescent and adult PWCF in the UK.
2. Explore the baseline characteristics of PWCF using different ACT’s.
Methods: Demographic data, spirometry, annual total intravenous antibiotics days and primary ACT
of all PWCF aged 11 years or older were obtained from the UK CF registry. These data were collected
during annual reviews from January to December 2011. Descriptive statistics and comparison with
results from other countries were performed.
Results: Forced expiratory techniques were the most common recorded form of primary ACT (28.1%),
followed by oscillating positive expiratory pressure (22.8%) and exercise (15.9%). PWCF who did
not use any form of ACT or used exercise as their primary ACT appeared to have the mildest lung
disease based on % predicted FEV1 (median 77.7%) and annual intravenous antibiotics days (median
0). PWCF using high frequency chest wall oscillation appeared to have the most severe lung disease,
with median % predicted FEV1 of 62.5% and median annual intravenous antibiotics days of 25.5.
The proportions of different ACT’s used in the UK were broadly similar to Canada.
Table: ACT use in the UK compared with other countries
Airway clearance techniques UK data
(n = 6372)
Canada data
(n = 2363),
McIlwaine
et al. 2008
Argentina data
(n = 110), Ratto
et al. 2012
US data
(n = 204),
Sawicki
et al. 2009
Manual techniques (Postural drainage and Forced
expiratory techniques)
32.5% 25% 86.3% 44%
Airway clearance devices (PEP and Oscillating PEP) 38.6% 48% 10.9% 15%
Other devices (e.g. high frequency chest wall oscillation) 1.8% 3% Not available 37%
Conclusion: A number of factors at PWCF, therapist and country level may inﬂuence choice of
ACT’s used in the UK.
We thank the UK CF Registry for supplying the data for this analysis.
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With improved survival, there are increasing numbers of CF patients who are adults.
CF Registry of Ireland (CFRI) data shows 52.1% of the CF population to be 18 yrs
and over. This study aims to describe the health status of the older CF population
and compare these results with previously published data.
A retrospective chart-based review of patients 30 yrs and older attending Cork Adult
CF Centre, CUH, was performed. Genotypic and phenotypic characteristics over
a 12-month period were recorded. These variables were compared to previously
collected departmental data and national/international reports.
25% (34/134) are 30 years and older. Of these, 56.5% have class 1−3 genotypic
mutations, a lower proportion than departmental (74%) and CFRI (69%) data. 55.9%
grew Pseudomonas in their sputum, lower than CFRI (65%) and Australian Registry
(80−87%) reports. The mean age-of-diagnosis was 12.8 yrs; Canadian Registry data
reports a mean of 3.2years. The median FEV1 was 67% predicted (range 21–125%),
greater than departmental (64%), CFRI (60%) and Australian Registry (55−65%)
reports. The median BMI was 24 (range 17.9–31.2), greater than departmental
(22.7) and Canadian Registry (21−23) data. There was a decreased prevalence of
pancreatic insufﬁciency, and an increased prevalence of CF-Related Diabetes, 59%
and 38% respectively, when compared to departmental data (82% and 22%), CFRI-
data (90% and 26%) and the Canadian Registry (85% and 21%). 11.8% (4/34) are
actively awaiting transplant.
25% of adult CF patients who attend CUH CF clinic are 30 yrs and older. This
group of patients was shown to be an inherently different group to their younger
adult counterparts.
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Objectives: Adolescence − a certain period of life between childhood and adulthood
is characterized by neuroendocrine changes, hormonal and metabolic features,
intense growth processes and sexual maturation. In this period of life chronic
diseases often have decompensation of organs and systems function that require
special attention from the medical staff and parents. The aim was to investigate the
clinical characteristics of CF in adolescents (15−18 years) of the Moscow region
in 2010.
Methods: CF Patients’ record notes were analysed. In 2010 160 CF patients were
under the care.
Results: Among the CF population there were 42 adolescents (11.7%), 22 male
patients, with the age at diagnosis of 3.9±1.6 years. That was signiﬁcantly higher
than in other age groups of children, but lower than in the group of adults
(p< 0.001). The number of deaths in adolescents group was 12.5% of total deaths.
In the group of adolescents there were less homozygotes for F508del (26.2%)
compared with younger children (32.1%). Sweat Test chlorides in adolescents
during the period of CF diagnosis were lower (84 [68.25–105] mmol/L) than
in children under 1 year at the time of diagnosis − 107.5 [10–113.5] mmol/L
(p< 0.05). Pancreatic insufﬁciency was present in 40 (95.24%) adolescents, in
the group <3 years − in 100% and in adult patients (>30 years old) − 71.4%.
10% of adolescents were infected with Burkholderia cepacia comlex. There was
an increased amount of diabetes and other complications of CF.
Conclusion: CF adolescents are characterized by several speciﬁc clinical features
that should be carefully monitored during the regular clinical examination.
